ROYALTY PHARMA PLC's ticker is and the CUSIP is G7709Q954. A total of 3 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,955 | +110.5% | 182,600 | +138.4% | 0.00% | +100.0% |
| Q2 2023 | $2,354 | +96.8% | 76,600 | +130.7% | 0.00% | +100.0% |
| Q1 2023 | $1,196 | -17.1% | 33,200 | -9.0% | 0.00% | -50.0% |
| Q4 2022 | $1,442 | -99.9% | 36,500 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $1,350,000 | +211.8% | 33,600 | +226.2% | 0.00% | – |
| Q2 2022 | $433,000 | +37.5% | 10,300 | +27.2% | 0.00% | – |
| Q1 2022 | $315,000 | -82.9% | 8,100 | -82.5% | 0.00% | -100.0% |
| Q4 2021 | $1,841,000 | +198.9% | 46,200 | +216.4% | 0.00% | +100.0% |
| Q3 2021 | $616,000 | +3.0% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $598,000 | +169.4% | 14,600 | +28527.5% | 0.00% | – |
| Q1 2021 | $222,000 | -68.3% | 51 | -63.6% | 0.00% | -100.0% |
| Q4 2020 | $700,000 | +192.9% | 140 | +145.6% | 0.00% | – |
| Q3 2020 | $239,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 140 | $700,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 400 | $20,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |